If you have a question for our guest, host or DRG please submit it here.
Will healthcare change after COVID-19?
Guest: Richard Erwin, General Manager and Managing Director, Roche Products Ltd (UK)
In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Richard Erwin, General Manager and Managing Director of Roche Products Ltd (UK). Mike and Richard discuss what companies can learn from the pandemic and if the business world will operate the same way as before. Richard shared how they sped up their clinical trial lead time, from initial discussions through to first patient, to under a month (normally this could take a year)! Richard also talks about the new ways of doing things in healthcare such as telephone calls with patients. Watch the full interview here.
About our Guest
Richard Erwin, General Manager and Managing Director, Roche Products Ltd (UK)
Richard joined Roche in 1989, beginning his career in UK sales, clinical research and marketing, later moving into European and Global leadership roles. He moved to Roche in Basel, Switzerland as Head of Commercial Development then Commercial Director - European region. Later, he became GM for Finland. Richard led the development of the immunology portfolio working with Japan and the US.
Richard was also the GM in Belgium where he sought to address the key challenges in securing patient access to important medicines, and is a member of the ABPI board, the board co-sponsor of the Value & Access Committee and the Welsh ABPI group.
About our Host
Mike Ward, Head of Thought Leadership, DRG
Mike Ward serves as Global Head of Thought Leadership at Decision Resources Group (DRG), part of Clarivate. As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial and content leadership roles at various publications and organizations across the industry.